The Journal of Pediatrics
Volume 155, Issue 3 , Pages 324-330.e1 , September 2009

A Multicenter, Randomized, Placebo-Controlled Trial of Prophylactic Recombinant Granulocyte-Colony Stimulating Factor in Preterm Neonates with Neutropenia

  • Pierre Kuhn, MD

      Affiliations

    • Réanimation néonatale, Service de Pédiatrie 2, Hôpital de Hautepierre, CHRU Strasbourg, France
    • Faculté de Médecine, Université Louis Pasteur Strasbourg, France
    • Corresponding Author InformationReprint requests: Pierre Kuhn, MD, Médecine et Réanimation Néonatale, Service de Pédiatrie 2, Hôpital de Hautepierre, Centre Hospitalier Universitaire de Strasbourg, Avenue Molière 67098, Strasbourg, France.
    • ,
  • Jean Messer, MD

      Affiliations

    • Réanimation néonatale, Service de Pédiatrie 2, Hôpital de Hautepierre, CHRU Strasbourg, France
    • Faculté de Médecine, Université Louis Pasteur Strasbourg, France
    • ,
  • Alain Paupe, MD

      Affiliations

    • Réanimation néonatale, Hôpital de Poissy-Saint Germain, CHI Poissy, France
    • ,
  • Sandrine Espagne, MD

      Affiliations

    • Réanimation néonatale, Maternité Régionale Universitaire de Nancy, France
    • ,
  • Nadine Kacet, MD

      Affiliations

    • Department of Perinatal Medicine, Hôpital Jeanne de Flandre, CHRU Lille, France
    • ,
  • Genevieve Mouchnino, MD

      Affiliations

    • Médecine et réanimation néonatale, Centre Hospitalier René Dubos Pontoise, France
    • ,
  • Serge Klosowski, MD

      Affiliations

    • Réanimation néonatale, Centre Hospitalier de Lens, France
    • ,
  • Gérard Krim, MD

      Affiliations

    • Réanimation néonatale, CHU Amiens, France
    • ,
  • Sandra Lescure, MD

      Affiliations

    • Service de médecine néonatale Port Royal, Groupe Hospitalier Cochin Paris, France
    • ,
  • Stephane Le Bouedec, MD

      Affiliations

    • Unité de Néonatologie, Pôle enfant, CHU Angers, France
    • ,
  • Pierre Meyer, MD

      Affiliations

    • Faculté de Médecine, Université Louis Pasteur Strasbourg, France
    • ,
  • Dominique Astruc, MD

      Affiliations

    • Réanimation néonatale, Service de Pédiatrie 2, Hôpital de Hautepierre, CHRU Strasbourg, France
    • Faculté de Médecine, Université Louis Pasteur Strasbourg, France

Received 25 September 2008 ,Revised 20 January 2009 ,Accepted 11 March 2009.

References 

  1. Stoll BJ, Hansen N, Fanaroff AA, Wright LL, Carlo WA, Ehrenkranz RA, et al. Late-onset sepsis in very low birth weight neonates: the experience of the NICHD Neonatal Research Network. Pediatrics. 2002;110:285–291
  2. Stoll BJ, Hansen NI, Adams-Chapman I, Fanaroff AA, Hintz SR, Vohr B, et al. Neurodevelopmental and growth impairment among extremely low birth weight infants with neonatal infection. JAMA. 2004;292:2357–2365
  3. Koenig JM, Christensen RD. Incidence, neutrophil kinetics, and natural history of neonatal neutropenia associated with maternal hypertension. N Engl J Med. 1989;321:557–562
  4. Cadnapaphornchai M, Faix RG. Increased nosocomial infection in neutropenic low birth weight (2000 grams or less) infants of hypertensive mothers. J Pediatr. 1992;121:956–961
  5. Gray PH, Rodwell RL. Neonatal neutropenia associated with maternal hypertension poses a risk for nosocomial infection. Eur J Pediatr. 1999;158:71–73
  6. La Gamma EF, Alpan O, Kocherlakota P. Effect of granulocyte colony-stimulating factor on preeclampsia-associated neonatal neutropenia. J Pediatr. 1995;126:457–459
  7. Makhlouf RA, Doron MW, Bose CL, Price WA, Stiles AD. Administration of granulocyte colony-stimulating factor to neutropenic low birth weight infants of mothers with preeclampsia. J Pediatr. 1995;126:454–456
  8. Kocherlakota P, La Gamma EF. Preliminary report: rhG-CSF may reduce the incidence of neonatal sepsis in prolonged preeclampsia-associated neutropenia. Pediatrics. 1998;102:1107–1111
  9. Miura E, Procianoy RS, Bittar C, Miura CS, Miura MS, Mello C, et al. A randomized, double-masked, placebo-controlled trial of recombinant granulocyte colony-stimulating factor administration to preterm infants with the clinical diagnosis of early-onset sepsis. Pediatrics. 2001;107:30–35
  10. Papoff P. Infection, neutrophils, and hematopoietic growth factors in the pathogenesis of neonatal chronic lung disease. Clin Perinatol. 2000;27:717–731
  11. Benitz WE, Han MY, Madan A, Ramachandra P. Serial serum C-reactive protein levels in the diagnosis of neonatal infection. Pediatrics. 1998;102:e41
  12. Carr R, Modi N, Dore CJ, El-Rifai R, Lindo D. A randomized, controlled trial of prophylactic granulocyte-macrophage colony-stimulating factor in human newborns less than 32 weeks gestation. Pediatrics. 1999;103:796–802
  13. Barak Y, Leibovitz E, Mogilner B, Juster-Reicher A, Amitay M, Ballin A, et al. The in vivo effect of recombinant human granulocyte-colony stimulating factor in neutropenic neonates with sepsis. Eur J Pediatr. 1997;156:643–646
  14. Drossou-Agakidou V, Kanakoudi-Tsakalidou F, Sarafidis K, Taparkou A, Tzimouli V, Tsandali H, et al. Administration of recombinant human granulocyte-colony stimulating factor to septic neonates induces neutrophilia and enhances the neutrophil respiratory burst and beta2 integrin expression: results of a randomized controlled trial. Eur J Pediatr. 1998;157:583–588
  15. Gillan ER, Christensen RD, Suen Y, Ellis R, van de Ven C, Cairo MS. A randomized, placebo-controlled trial of recombinant human granulocyte colony-stimulating factor administration in newborn infants with presumed sepsis: significant induction of peripheral and bone marrow neutrophilia. Blood. 1994;84:1427–1433
  16. Ahmad M, Fleit HB, Golightly MG, La Gamma EF. In vivo effect of recombinant human granulocyte colony-stimulating factor on phagocytic function and oxidative burst activity in septic neutropenic neonates. Biol Neonate. 2004;86:48–54
  17. Bedford Russell AR, Emmerson AJ, Wilkinson N, Chant T, Sweet DG, Halliday HL, et al. A trial of recombinant human granulocyte colony stimulating factor for the treatment of very low birthweight infants with presumed sepsis and neutropenia. Arch Dis Child Fetal Neonatal Ed. 2001;84:F172–F176
  18. Kocherlakota P, La Gamma EF. Human granulocyte colony-stimulating factor may improve outcome attributable to neonatal sepsis complicated by neutropenia. Pediatrics. 1997;100:e6
  19. Buhrer C, Stibenz D, Graulich J, Gernhold U, Butcher EC, Dudenhausen JW, et al. Soluble L-selectin (sCD62L) umbilical cord plasma levels increase with gestational age. Pediatr Res. 1995;38:336–341
  20. Koenig JM, Yoder MC. Neonatal neutrophils: the good, the bad, and the ugly. Clin Perinatol. 2004;31:39–51
  21. Gessler P, Kirchmann N, Kientsch-Engel R, Haas N, Lasch P, Kachel W. Serum concentrations of granulocyte colony-stimulating factor in healthy term and preterm neonates and in those with various diseases including bacterial infections. Blood. 1993;82:3177–3182
  22. Funke A, Berner R, Traichel B, Schmeisser D, Leititis JU, Niemeyer CM. Frequency, natural course, and outcome of neonatal neutropenia. Pediatrics. 2000;106:45–51
  23. Bernstein HM, Pollock BH, Calhoun DA, Christensen RD. Administration of recombinant granulocyte colony-stimulating factor to neonates with septicemia: a meta-analysis. J Pediatr. 2001;138:917–920
  24. Bartels DB, Schwab F, Geffers C, Poets CF, Gastmeier P. Nosocomial infection in small for gestational age newborns with birth weight < 1500 g: a multicentre analysis. Arch Dis Child Fetal Neonatal Ed. 2007;92:F449–F453
  25. Omar SA, Salhadar A, Wooliever DE, Alsgaard PK. Late-onset neutropenia in very low birth weight infants. Pediatrics. 2000;106:e55
  26. Bilgin K, Yaramis A, Haspolat K, Tas MA, Gunbey S, Derman O. A randomized trial of granulocyte-macrophage colony-stimulating factor in neonates with sepsis and neutropenia. Pediatrics. 2001;107:36–41
  27. Cairo MS, Agosti J, Ellis R, Laver JJ, Puppala B, deLemos R, et al. A randomized, double-blind, placebo-controlled trial of prophylactic recombinant human granulocyte-macrophage colony-stimulating factor to reduce nosocomial infections in very low birth weight neonates. J Pediatr. 1999;134:64–70
  28. Cairo MS, Christensen R, Sender LS, Ellis R, Rosenthal J, van de Ven C, et al. Results of a phase I/II trial of recombinant human granulocyte-macrophage colony-stimulating factor in very low birthweight neonates: significant induction of circulatory neutrophils, monocytes, platelets, and bone marrow neutrophils. Blood. 1995;86:2509–2515
  29. Schibler KR, Osborne KA, Leung LY, Le TV, Baker SI, Thompson DD. A randomized, placebo-controlled trial of granulocyte colony-stimulating factor administration to newborn infants with neutropenia and clinical signs of early-onset sepsis. Pediatrics. 1998;102:6–13
  30. Simmonds A, LaGamma EF. NEC Part 2. Toward improving mucosal barrier defenses: rhG-CSF plus IgG antibody. Indian J Pediatr. 2006;73:1019–1026
  31. Wolkoff LI, Levine CR, Koo HC, LaGamma EF, Pollack S, Chester D, et al. Effects of granulocyte colony-stimulating factor on hyperoxia-induced lung injury in newborn piglets. Lung. 2002;180:229–239
  32. Rosenthal J, Healey T, Ellis R, Gillan E, Cairo MS. A two-year follow-up of neonates with presumed sepsis treated with recombinant human granulocyte colony-stimulating factor during the first week of life. J Pediatr. 1996;128:135–137
  33. Donadieu J, Leblanc T, Bader Meunier B, Barkaoui M, Fenneteau O, Bertrand Y, et al. Analysis of risk factors for myelodysplasias, leukemias and death from infection among patients with congenital neutropenia: experience of the French Severe Chronic Neutropenia Study Group. Haematologica. 2005;90:45–53
  34. Freedman MH, Bonilla MA, Fier C, Bolyard AA, Scarlata D, Boxer LA, et al. Myelodysplasia syndrome and acute myeloid leukemia in patients with congenital neutropenia receiving G-CSF therapy. Blood. 2000;96:429–436
  35. Glass HC, Bonifacio SL, Chau V, Glidden D, Poskitt K, Barkovich AJ, et al. Recurrent postnatal infections are associated with progressive white matter injury in premature infants. Pediatrics. 2008;122:299–305

 Supported by the Programme Hospitalier de Recherche Clinique National of the French Ministry of Health (020322). The authors declare no conflicts of interest.

 Registered at www.clinicaltrials.gov: NCT00213759.

PII: S0022-3476(09)00241-8

doi: 10.1016/j.jpeds.2009.03.019

The Journal of Pediatrics
Volume 155, Issue 3 , Pages 324-330.e1 , September 2009

Article Tools

* Image Usage & Resolution